Polycystic ovary syndrome and cardiovascular risk. Could trimethylamine N-oxide (TMAO) be a major player? A potential upgrade forward in the DOGMA theory.
Biomed Pharmacother
; 143: 112171, 2021 Nov.
Article
de En
| MEDLINE
| ID: mdl-34536755
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Syndrome des ovaires polykystiques
/
Bactéries
/
Maladies cardiovasculaires
/
Microbiome gastro-intestinal
/
Méthylamines
Type d'étude:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limites:
Animals
/
Female
/
Humans
Langue:
En
Journal:
Biomed Pharmacother
Année:
2021
Type de document:
Article
Pays de publication:
France